Inger Ødum Nielsen

Inger Ødum Nielsen is a Senior Medical Writer at Novo Nordisk since January 2022 and has served as a Medical Writer. Concurrently, Inger Ødum Nielsen has been a Postdoctoral Researcher at Kræftens Bekæmpelse (Danish Cancer Society) since January 2016, building on prior experience as a PhD Student. Additional experience includes a position as a Visiting Predoctoral Fellow at EMBL in October 2018, and various student assistant roles at Finsen Laboratory and Carlsberg Laboratory, as well as a Laboratory Assistant position at the Department of Paediatrics and Adolescent Medicine. Inger Ødum Nielsen holds a PhD in Molecular Biomedicine from Københavns Universitet (2016-2019), a Master’s degree from the same institution (2013-2015), and a Bachelor's degree in Molecular Biomedicine (2009-2013), complemented by summer studies in Epidemiology at Erasmus University and an exchange program at The University of Hong Kong.